article thumbnail

Liraglutide Helped Cut BMI in Kids With Obesity as Young as 6

Med Page Today

(MedPage Today) -- Liraglutide (Saxenda) added to lifestyle intervention helped reduce BMI in young children with obesity, the phase IIIa SCALE Kids trial found. By week 56, kids, ages 6 to <12 years, on once-daily 3-mg liraglutide lost 5.8.

BMI 111
article thumbnail

Higher BMI variability linked to adverse cardiovascular disease events

Medical Xpress - Cardiology

Higher body mass index (BMI) variability is associated with adverse cardiovascular disease (CVD) events, according to a study published online March 21 in JAMA Network Open.

BMI 88
article thumbnail

Genetically predicted smoking and body mass index mediate the relationship between insomnia and myocardial infarction

Frontiers in Cardiovascular Medicine

Genetic instruments for MI, smoking initiation, alcohol consumption, and BMI were derived from large-scale genome-wide association studies. Smoking initiation and BMI were identified as potential mediators. ConclusionsThe results of this MR analysis demonstrate that insomnia increases the risk of MI.

article thumbnail

Mazen Noureddin, MD: Differences in Resmetirom Efficacy Based on Body Weight, BMI

HCPLive

Noureddin explains the efficacy of resmetirom doses and how they vary based on patients’ body weight and BMI, supporting current prescribing practices.

BMI 64
article thumbnail

NOAC vs. Warfarin for AF Across BMI and Body Weight

American College of Cardiology

What is the efficacy and safety of non–vitamin-K antagonist oral anticoagulants (NOACs) across the spectrum of body mass index (BMI) and body weight (BW)?

BMI 68
article thumbnail

Tirzepatide Sheds Pounds in Chinese Adults With BMI as Low as 24

Med Page Today

(MedPage Today) -- Tirzepatide (Zepbound) was effective at reducing body weight in Chinese adults with lower cutoffs for overweight or obesity, the SURMOUNT-CN trial reported. In the study of 210 adults without diabetes, participants on tirzepatide.

BMI 104
article thumbnail

NAFLD Presents Similar Risk for Adverse Outcomes Regardless of BMI

HCPLive

Patients with lean NAFLD had fewer metabolic comorbidities but maintained similar risk of NASH, cirrhosis, nonliver cancer, and mortality compared to their overweight and obese counterparts.

BMI 105